Eyecuracy

Company Overview

Snapshot

Founded in March 2022 by Albert Kashchenevsky, Eyecuracy operates with 1-10 employees. The company has raised $1.3 million across one funding round from one investor. In January 2024, Eyecuracy secured Seed funding from Random Forest VC.

Business overview

Eyecuracy is a Health Tech & Life Sciences company developing a hybrid healthcare platform for the diagnostics, monitoring, and treatment of neurological and neuro-ophthalmological disorders. The platform integrates user-friendly hardware, a smart cloud service, and proprietary AI algorithms for accurate eye tracking. It aims to provide convenient and cost-effective patient care through in-office diagnosis, home monitoring, and personalized treatment options, addressing challenges of subjective diagnostics and low adherence. The company's core technology focuses on an AI-powered eye-tracking algorithm that accurately locates the optical axis by analyzing the cornea perimeter, distinguishing it from other solutions that rely on infrared cornea reflections.

Company Intelligence Q&A

What is Eyecuracy's primary product offering?

Eyecuracy offers a hybrid healthcare platform for the diagnostics, monitoring, and treatment of neurological and neuro-ophthalmological disorders, featuring AI-powered eye tracking.

When was Eyecuracy founded?

Eyecuracy was founded in March 2022.

Who is the founder of Eyecuracy?

Eyecuracy was founded by Albert Kashchenevsky.

What is Eyecuracy's current product stage?

Eyecuracy's product is currently in the Clinical Trial stage, focusing on developing a hybrid healthcare platform for neurological and neuro-ophthalmological disorders.

Which markets does Eyecuracy target?

Eyecuracy targets geomarkets in Europe, North America, and Asia.